Washington, DC—Last month, both the National Institutes of Health and the US Food and Drug Administration announced plans to phase out the use of animals in scientific research. The Animal Welfare ...

Clinical trials are facing a crisis amid growing delays, diminishing success rates and rising costs. Companies across the stakeholder spread are investing in AI to ease some of the longstanding ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development. Earlier this week, the UK’s science minister announced an ambitious plan: to phase out ...

Add Task & Purpose (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. The Pentagon’s ...

TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of ...

Forbes contributors publish independent expert analyses and insights. Sara Schapiro writes about education, innovation, and public policy. Jan 21, 2025, 03:31pm EST Jan 24, 2025, 03:40pm EST Education ...